Skip to main content

Identifying determinants of persistent MRSA bacteremia using mathematical modeling.

Publication ,  Journal Article
Mikkaichi, T; Yeaman, MR; Hoffmann, A; MRSA Systems Immunobiology Group,
Published in: PLoS Comput Biol
July 2019

Persistent bacteremia caused by Staphylococcus aureus (SA), especially methicillin-resistant SA (MRSA), is a significant cause of morbidity and mortality. Despite susceptibility phenotypes in vitro, persistent MRSA strains fail to clear with appropriate anti-MRSA therapy during bacteremia in vivo. Thus, identifying the factors that cause such MRSA persistence is of direct and urgent clinical relevance. To address the dynamics of MRSA persistence in the face of host immunity and typical antibiotic regimens, we developed a mathematical model based on the overarching assumption that phenotypic heterogeneity is a hallmark of MRSA persistence. First, we applied an ensemble modeling approach and obtained parameter sets that satisfied the condition of a minimum inoculum dose to establish infection. Second, by simulating with the selected parameter sets under vancomycin therapy which follows clinical practices, we distinguished the models resulting in resolving or persistent bacteremia, based on the total SA exceeding a detection limit after five days of treatment. Third, to find key determinants that discriminate resolving and persistent bacteremia, we applied a machine learning approach and found that the immune clearance rate of persister cells is a key feature. But, fourth, when relapsing bacteremia was considered, the growth rate of persister cells was also found to be a key feature. Finally, we explored pharmacological strategies for persistent and relapsing bacteremia and found that a persister killer, but not a persister formation inhibitor, could provide for an effective cure the persistent bacteremia. Thus, to develop better clinical solutions for MRSA persistence and relapse, our modeling results indicate that we need to better understand the pathogen-host interactions of persister MRSAs in vivo.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PLoS Comput Biol

DOI

EISSN

1553-7358

Publication Date

July 2019

Volume

15

Issue

7

Start / End Page

e1007087

Location

United States

Related Subject Headings

  • Staphylococcal Infections
  • Models, Theoretical
  • Microbial Sensitivity Tests
  • Methicillin-Resistant Staphylococcus aureus
  • Male
  • Humans
  • Female
  • Bioinformatics
  • Bacteremia
  • Anti-Bacterial Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mikkaichi, T., Yeaman, M. R., Hoffmann, A., & MRSA Systems Immunobiology Group, . (2019). Identifying determinants of persistent MRSA bacteremia using mathematical modeling. PLoS Comput Biol, 15(7), e1007087. https://doi.org/10.1371/journal.pcbi.1007087
Mikkaichi, Tsuyoshi, Michael R. Yeaman, Alexander Hoffmann, and Alexander MRSA Systems Immunobiology Group. “Identifying determinants of persistent MRSA bacteremia using mathematical modeling.PLoS Comput Biol 15, no. 7 (July 2019): e1007087. https://doi.org/10.1371/journal.pcbi.1007087.
Mikkaichi T, Yeaman MR, Hoffmann A, MRSA Systems Immunobiology Group. Identifying determinants of persistent MRSA bacteremia using mathematical modeling. PLoS Comput Biol. 2019 Jul;15(7):e1007087.
Mikkaichi, Tsuyoshi, et al. “Identifying determinants of persistent MRSA bacteremia using mathematical modeling.PLoS Comput Biol, vol. 15, no. 7, July 2019, p. e1007087. Pubmed, doi:10.1371/journal.pcbi.1007087.
Mikkaichi T, Yeaman MR, Hoffmann A, MRSA Systems Immunobiology Group. Identifying determinants of persistent MRSA bacteremia using mathematical modeling. PLoS Comput Biol. 2019 Jul;15(7):e1007087.

Published In

PLoS Comput Biol

DOI

EISSN

1553-7358

Publication Date

July 2019

Volume

15

Issue

7

Start / End Page

e1007087

Location

United States

Related Subject Headings

  • Staphylococcal Infections
  • Models, Theoretical
  • Microbial Sensitivity Tests
  • Methicillin-Resistant Staphylococcus aureus
  • Male
  • Humans
  • Female
  • Bioinformatics
  • Bacteremia
  • Anti-Bacterial Agents